Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Dicato

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Journal of Medicinal Chemistry|May 6, 2017
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell LinesMichael Schnekenburger, Eric Goffin, Jin-Young Lee, et al.
Cancer Letters|September 12, 2018
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP releaseAloran Mazumder, Jin-Young Lee, Oualid Talhi, et al.
Frontiers in Pharmacology|March 17, 2018
Cardiac Glycoside Glucoevatromonoside Induces Cancer Type-Specific Cell DeathNaira F Z Schneider, Claudia Cerella, Jin-Young Lee, et al.
Cancer Letters|December 17, 2017
The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancerSeungwon Ji, Jin-Young Lee, Jan Schrör, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Journal of Medicinal Chemistry|May 6, 2017
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell LinesMichael Schnekenburger, Eric Goffin, Jin-Young Lee, et al.
Cancer Letters|September 12, 2018
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP releaseAloran Mazumder, Jin-Young Lee, Oualid Talhi, et al.
Frontiers in Pharmacology|March 17, 2018
Cardiac Glycoside Glucoevatromonoside Induces Cancer Type-Specific Cell DeathNaira F Z Schneider, Claudia Cerella, Jin-Young Lee, et al.
Cancer Letters|December 17, 2017
The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancerSeungwon Ji, Jin-Young Lee, Jan Schrör, et al.
Pageof 16